Search - tctmd.com

Displaying 41 - 60 of 287

Sort: Relevancy | Date

News Daily News

Leaflet Thrombosis After TAVR Not Linked With Stroke, TIA, or Mortality Risk

Michael O'Riordan

June 20, 2018

News Conference News SCAI 2018

3-D Printing May Help TAVR Operators Avoid Paravalvular Leak

L.A. McKeown

April 26, 2018

News Daily News

Valve-in-Valve TAVR: Mortality, Adverse Events Similar to Redo Surgery at 30 Days

Yael L. Maxwell

April 25, 2018

News Conference News CRT 2018

Transcatheter Fix for Native Aortic Valve Regurgitation ‘Not Optimal’ but Getting Better

Shelley Wood

March 05, 2018

News Daily News

New-Generation TAVR Devices Outperform Predecessors in Treating Pure Native AR: Registry

Caitlin E. Cox

November 30, 2017

News Conference News AHA 2017

More Support for TMVR After Failed Mitral Bioprostheses

Yael L. Maxwell

November 23, 2017

News Conference News TCT 2017

A-fib Signals Worse Prognosis After Aortic Valve Replacement in Intermediate-Risk Patients

Todd Neale

November 08, 2017

News Conference News TCT 2017

One in Six Patients With LBBB Post-TAVR Develop Atrioventricular Block

Michael O'Riordan

October 31, 2017

News Conference News TCT 2017

Intermediate-Risk TAVR Substantially More Cost-effective Than Surgery

Yael L. Maxwell

October 31, 2017

News Conference News TCT 2017

Live From Denver: TCT 2017, Day Two

Shelley Wood

October 31, 2017

News Conference News ESC 2017

Nonagenarians Fare Well After TAVR, Once They Get Beyond 30 Days

Michael O'Riordan

August 31, 2017

News Daily News

FDA Expands CoreValve Indication to Include Intermediate-Risk Patients

Michael O'Riordan

July 10, 2017

News Daily News

TAVR Use Triples in France, With Docs Treating Lower-Risk Patients

Michael O'Riordan

June 26, 2017

News Conference News TVT 2017

Lagging Behind: Guidelines Can’t Keep Up With Growing TAVR Evidence Base

Michael O'Riordan

June 17, 2017

News Conference News TVT 2017

Q&A: Transcatheter Valve Innovation Past, Present, and Future as TVT Turns 10

Shelley Wood

June 12, 2017

News Daily News

FDA Expands Sapien 3 Indication to Aortic, Mitral Valve-in-Valve Replacement

Michael O'Riordan

June 06, 2017

News Conference News EuroPCR 2017

Bicuspid AS Patients with Calcification Fare Worse After TAVR, But Device Type Matters

Michael O'Riordan

May 17, 2017

News Conference News EuroPCR 2017

The ARTE of Antiplatelet Therapy After TAVR: Bleeding Greater with Clopidogrel Plus Aspirin vs Aspirin Alone

Yael L. Maxwell

May 17, 2017

News Daily News

Updated PARTNER 2 Valve-in-Valve Registry: More Experience, Better Outcomes

Shelley Wood

May 02, 2017

News Daily News

Permanent Pacemakers After TAVR: Model Helps Predict Individual Patient Risk With Sapien 3

L.A. McKeown

April 12, 2017

Advertisement

Leaflet Thrombosis After TAVR Not Linked With Stroke, TIA, or Mortality Risk

3-D Printing May Help TAVR Operators Avoid Paravalvular Leak

Valve-in-Valve TAVR: Mortality, Adverse Events Similar to Redo Surgery at 30 Days

Transcatheter Fix for Native Aortic Valve Regurgitation ‘Not Optimal’ but Getting Better

New-Generation TAVR Devices Outperform Predecessors in Treating Pure Native AR: Registry

More Support for TMVR After Failed Mitral Bioprostheses

A-fib Signals Worse Prognosis After Aortic Valve Replacement in Intermediate-Risk Patients

One in Six Patients With LBBB Post-TAVR Develop Atrioventricular Block

Intermediate-Risk TAVR Substantially More Cost-effective Than Surgery

Live From Denver: TCT 2017, Day Two

Nonagenarians Fare Well After TAVR, Once They Get Beyond 30 Days

FDA Expands CoreValve Indication to Include Intermediate-Risk Patients

TAVR Use Triples in France, With Docs Treating Lower-Risk Patients

Lagging Behind: Guidelines Can’t Keep Up With Growing TAVR Evidence Base

Q&A: Transcatheter Valve Innovation Past, Present, and Future as TVT Turns 10

FDA Expands Sapien 3 Indication to Aortic, Mitral Valve-in-Valve Replacement

Bicuspid AS Patients with Calcification Fare Worse After TAVR, But Device Type Matters

The ARTE of Antiplatelet Therapy After TAVR: Bleeding Greater with Clopidogrel Plus Aspirin vs Aspirin Alone

Updated PARTNER 2 Valve-in-Valve Registry: More Experience, Better Outcomes

Permanent Pacemakers After TAVR: Model Helps Predict Individual Patient Risk With Sapien 3

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content